{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:38:19Z","timestamp":1758044299956,"version":"3.44.0"},"reference-count":83,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128160787"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-12-801238-3.11611-3","type":"book-chapter","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T17:42:10Z","timestamp":1592070130000},"page":"97-110","source":"Crossref","is-referenced-by-count":8,"title":["Antioxidant Therapy and Neurodegenerative Disorders: Lessons From Clinical Trials"],"prefix":"10.1016","author":[{"given":"C\u00e1tia","family":"Silva","sequence":"first","affiliation":[]},{"given":"Miguel","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Benfeito","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"year":"2016","series-title":"Reactive Oxygen Species in Biology and Human Health","author":"Ahmad","key":"10.1016\/B978-0-12-801238-3.11611-3_bb0010"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","article-title":"Antioxidant and radical scavenging properties of curcumin","volume":"174","author":"Ak","year":"2008","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: The reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radical Research"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0025","first-page":"S18","article-title":"Oxidative stress in neurodegeneration: Cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnology Advances"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnagi.2019.00155","article-title":"Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders","volume":"11","author":"Ayaz","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cbi.2013.10.022","article-title":"Enhanced antioxidant effect of caffeic acid phenethyl ester and Trolox in combination against radiation induced-oxidative stress","volume":"207","author":"Bai","year":"2014","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mito.2012.12.002","article-title":"Antioxidant therapy: Still in search of the \u201cmagic bullet\u201d","volume":"13","author":"Benfeito","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1358\/dot.2018.54.6.2828189","article-title":"Edaravone: A new hope for deadly amyotrophic lateral sclerosis","volume":"54","author":"Bhandari","year":"2018","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organization Journal"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1039\/c0mt00074d","article-title":"Role of metal dyshomeostasis in Alzheimer\u05f3s disease","volume":"3","author":"Bonda","year":"2011","journal-title":"Metallomics"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/oxim.3.4.12858","article-title":"Exogenous antioxidants\u2014Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses","volume":"3","author":"Bouayed","year":"2010","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0070","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1039\/c5mt00075k","article-title":"Selenium, selenoproteins and neurodegenerative diseases","volume":"7","author":"Cardoso","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4120458","article-title":"Recent advances in studies on the therapeutic potential of dietary carotenoids in neurodegenerative diseases","volume":"2018","author":"Cho","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrd3634","article-title":"Neurodegenerative disease: Novel ALS therapy shows promise in Phase II","volume":"11","author":"Crunkhorn","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0085","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.3390\/ijms15046002","article-title":"Oxidative stress in cardiovascular disease","volume":"15","author":"Cs\u00e1nyi","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","article-title":"Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): A randomised, double-blind, phase 3 trial","volume":"12","author":"Cudkowicz","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/138955710791330909","article-title":"Perspectives on medicinal properties of benzoquinone compounds","volume":"10","author":"Dandawate","year":"2010","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3164\/jcbn.11-006FR","article-title":"Myeloperoxidase-derived oxidation: Mechanisms of biological damage and its prevention","volume":"48","author":"Davies","year":"2011","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0105","doi-asserted-by":"crossref","first-page":"1245049","DOI":"10.1155\/2016\/1245049","article-title":"Role of ROS and RNS sources in physiological and pathological conditions","volume":"2016","author":"Di Meo","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0110","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1159\/000493831","article-title":"Inosine\u2014A multifunctional treatment for complications of neurologic injury","volume":"49","author":"Doyle","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jtemb.2016.03.010","article-title":"Iron chelation in the treatment of neurodegenerative diseases","volume":"38","author":"Dusek","year":"2016","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0125","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.2174\/0929867321666140915141836","article-title":"Nanotechnology and antioxidant therapy: An emerging approach for neurodegenerative diseases","volume":"21","author":"Fernandes","year":"2014","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0130","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.2174\/092986711803414368","article-title":"Antioxidant therapy: Current status and future prospects","volume":"18","author":"Firuzi","year":"2011","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10401230500296428","article-title":"A review of antioxidants and Alzheimer\u05f3s disease","volume":"17","author":"Frank","year":"2005","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0145","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1089\/ars.2011.3999","article-title":"Superoxide dismutases: Role in redox signaling, vascular function, and diseases","volume":"15","author":"Fukai","year":"2011","journal-title":"Antioxidants and Redox Signaling"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0150","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.2174\/09298673113209990155","article-title":"The use of flavonoids in central nervous system disorders","volume":"20","author":"Grosso","year":"2013","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ifset.2009.07.002","article-title":"Antioxidant properties of resveratrol: A structure\u2013activity insight","volume":"11","author":"G\u00fcl\u00e7in","year":"2010","journal-title":"Innovative Food Science & Emerging Technologies"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.nu.16.070196.000341","article-title":"Antioxidants in human health and disease","volume":"16","author":"Halliwell","year":"1996","journal-title":"Annual Review of Nutrition"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/07388551.2016.1207153","article-title":"Docosahexaenoic acid: One molecule diverse functions","volume":"37","author":"Hashimoto","year":"2017","journal-title":"Critical Reviews in Biotechnology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/abbi.1996.0510","article-title":"The metabolism of tyramine by monoamine oxidase A\/B causes oxidative damage to mitochondrial DNA","volume":"335","author":"Hauptmann","year":"1996","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1471-4159.1999.0721133.x","article-title":"Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats","volume":"72","author":"Hossain","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00702-009-0240-y","article-title":"Recent advances in our understanding of neurodegeneration","volume":"116","author":"Jellinger","year":"2009","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jtemb.2015.07.005","article-title":"Revised reference values for selenium intake","volume":"32","author":"Kipp","year":"2015","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.26499","article-title":"Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C","volume":"31","author":"Koga","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0195","doi-asserted-by":"crossref","first-page":"15924","DOI":"10.3390\/ijms150915924","article-title":"Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders","volume":"15","author":"Laudon","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","article-title":"Direct antioxidant properties of creatine","volume":"290","author":"Lawler","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0205","doi-asserted-by":"crossref","first-page":"24438","DOI":"10.3390\/ijms141224438","article-title":"Oxidative stress and neurodegenerative disorders","volume":"14","author":"Li","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0210","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1582-4934.2009.00897.x","article-title":"Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems","volume":"14","author":"L\u00fc","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0215","doi-asserted-by":"crossref","first-page":"3017947","DOI":"10.1155\/2017\/3017947","article-title":"Monoamine oxidases, oxidative stress, and altered mitochondrial dynamics in cardiac ageing","volume":"2017","author":"Maggiorani","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0220","series-title":"Free Radicals in Human Health and Disease","article-title":"Production of reactive oxygen species and its implication in human diseases","author":"Mani","year":"2015"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbabio.2014.03.010","article-title":"The H+-ATP synthase: A gate to ROS-mediated cell death or cell survival","volume":"1837","author":"Mart\u00ednez-Reyes","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0235","series-title":"NeuroImmune Biology","doi-asserted-by":"crossref","DOI":"10.1016\/S1567-7443(04)80027-9","article-title":"Possible new anti-ageing strategies related to neuroendocrine-immune interactions","author":"Mocchegiani","year":"2004"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0240","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnins.2019.00180","article-title":"Iron in neurodegeneration\u2014Cause or consequence?","volume":"13","author":"Ndayisaba","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0250","doi-asserted-by":"crossref","first-page":"27986","DOI":"10.1039\/C4RA13315C","article-title":"Free radicals, natural antioxidants, and their reaction mechanisms","volume":"5","author":"Nimse","year":"2015","journal-title":"RSC Advances"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0508-1","article-title":"RNA oxidation in Alzheimer disease and related neurodegenerative disorders","volume":"118","author":"Nunomura","year":"2009","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0260","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1100\/tsw.2010.104","article-title":"Thiol redox transitions in cell signaling: A lesson from N-acetylcysteine","volume":"10","author":"Parasassi","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/17425247.2016.1218461","article-title":"Mitochondria and neurodegenerative diseases: The promising role of nanotechnology in targeted drug delivery","volume":"14","author":"Pezzini","year":"2017","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0270","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","article-title":"Oxidative stress hypothesis in Alzheimer\u05f3s disease: A reappraisal","volume":"29","author":"Pratic\u00f2","year":"2008","journal-title":"Trends in Pharmacology Science"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0280","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: How are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0285","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bbadis.2017.06.004","article-title":"Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson\u05f3s disease","volume":"1863","author":"Rosa","year":"2017","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14737175.7.4.407","article-title":"Dementia syndromes: Evaluation and treatment","volume":"7","author":"Scott","year":"2007","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0295","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00726-011-0875-5","article-title":"Creatine as an antioxidant","volume":"40","author":"Sestili","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0300","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2013\/563481","article-title":"Neurodegenerative diseases: Multifactorial conformational diseases and their therapeutic interventions","volume":"2013","author":"Sheikh","year":"2013","journal-title":"Journal of Neurodegenerative Diseases"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-130722","article-title":"A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u05f3s disease","volume":"38","author":"Shinto","year":"2014","journal-title":"Journal of Alzheimer\u05f3s Disease"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0315","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative stress: A concept in redox biology and medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0320","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11030-018-9878-4","article-title":"A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer\u05f3s and Parkinson\u05f3s diseases","volume":"23","author":"Singh","year":"2019","journal-title":"Molecular Diversity"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","article-title":"Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications","volume":"1","author":"Skovronsky","year":"2006","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0330","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u05f3s disease","volume":"25","author":"Snow","year":"2010","journal-title":"Movement Disorders"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0335","first-page":"3725","article-title":"Tauroursodeoxycholic acid enhances mitochondrial biogenesis, neural stem cell pool, and early neurogenesis in adult rats","volume":"55","author":"Soares","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0340","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/jhh.2009.83","article-title":"Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure","volume":"24","author":"Spitsin","year":"2010","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0345","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: A nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0350","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2174\/1871523011320240001","article-title":"Alzheimer\u05f3s disease and antioxidant therapy: How long how far?","volume":"20","author":"Teixeira","year":"2013","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0355","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12199-007-0019-4","article-title":"Selenium: Its role as antioxidant in human health","volume":"13","author":"Tinggi","year":"2008","journal-title":"Environmental Health and Preventive Medicine"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/foods5010007","article-title":"Can xanthophyll-membrane interactions explain their selective presence in the retina and brain?","volume":"5","author":"Widomska","year":"2016","journal-title":"Food"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0370","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2015.12.024","article-title":"The influence of common free radicals and antioxidants on development of Alzheimer\u05f3s Disease","volume":"78","author":"Wojtunik-Kulesza","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0375","series-title":"Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders","article-title":"Chapter 1\u2014Neurodegenerative disorders: Why do we need new therapies?","author":"Yacoubian","year":"2017"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0380","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-3458.2006.00009.x","article-title":"Neuroprotective effects of edaravone: A novel free radical scavenger in cerebrovascular injury","volume":"12","author":"Yoshida","year":"2006","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0385","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: Preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"Journal of Alzheimer\u05f3s Disease"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0390","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tips.2016.06.007","article-title":"Targeting oxidative stress in central nervous system disorders","volume":"37","author":"Manisha","year":"2016","journal-title":"Trends in Pharmacological Disorders"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0395","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u05f3s disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0400","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3390\/molecules23123283","article-title":"The potential use of plant natural products and plant extracts with antioxidant properties for the prevention\/treatment of neurodegenerative diseases: In vitro, in vivo and clinical trials","volume":"23","author":"Pohl","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0405","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2174\/13816128113196660706","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u05f3s disease\u2014Challenges and perspectives","volume":"20","author":"Polidori","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0410","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1016\/j.bmc.2010.06.090","article-title":"Lipophilic phenolic antioxidants: Correlation between antioxidant profile, partition coefficients and redox properties","volume":"18","author":"Roleira","year":"2010","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0415","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2008.02.003","article-title":"Why have antioxidants failed in clinical trials?","volume":"101","author":"Steinhubl","year":"2008","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/B978-0-12-801238-3.11611-3_bb0420","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1021\/acs.jmedchem.7b00741","article-title":"Development of a mitochondriotropic antioxidant based on caffeic acid: Proof of concept on cellular and mitochondrial oxidative stress model","volume":"60","author":"Teixeira","year":"2017","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["Systems Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128012383116113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128012383116113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:56:52Z","timestamp":1757678212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128012383116113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128160787"],"references-count":83,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-801238-3.11611-3","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}